The case for clinical pathways in radiation oncology
A clinical pathways program would reduce the number of ways the same treatments are described within and across cancer programs. Failure to adhere to protocol specified radiation therapy guidelines was associated with decreased survival in RTOG 9704 a phase III trial of adjuvant chemotherapy and chemoradiotherapy for patients with resected adenocarcinoma of the pancreas.